TAVI: Direct Flow to put its valve up against Medtronic's CoreValve

The FDA says Direct Flow Medical can compare its transcatheter aortic valve implant with Medtronic's CoreValve in a clinical trial that's now slated to include a high-risk cohort.

Direct Flow Medical Inc., Food & Drug Administration (FDA), Medtronic

News Well, Clinical Trials, Replacement Heart Valves, TAVI

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1y8nirD